AURKA and lung cancer: Taken together, our results provide strong evidence that Aurora kinases are KRAS downstream effectors that play an important role in promoting the oncogenic phenotype, and suggest AURKA and/or AURKB inhibition as a promising approach to be explored alone or preferentially in combination with other strategies for KRAS-induced lung cancer therapy.